Cancer gene therapy of E1B-55 kD-deleted adenovirus on bladder cancer and hepatocellular carcinoma
博士 === 國立成功大學 === 基礎醫學研究所 === 92 === 英文摘要 Oncolytic adenoviruses are an innovative class of promising cancer therapeutics. The use of oncolytic adenoviruses as a cancer therapeutic is dependent on the lytic properties of the viral cycle, and the molecular differences between tumor cells and nontu...
Main Authors: | Jeng-long Hsieh, 謝政蓉 |
---|---|
Other Authors: | Ai-Li Shiau |
Format: | Others |
Language: | zh-TW |
Published: |
2004
|
Online Access: | http://ndltd.ncl.edu.tw/handle/71020801933430330498 |
Similar Items
-
The Cells Death Mechanism Induced by E1B-55K-deleted Conditionally Replicating Adenovirus and CB1954 Sensitization Gene Therapy in Hepatocellular Carcinoma Cells
by: Lai, Jian-Han, et al.
Published: (2015) -
Beyond Oncolytics: E1B55K-Deleted Adenovirus as a Vaccine Delivery Vector.
by: Michael A Thomas, et al.
Published: (2016-01-01) -
Comparative Effect of Oncolytic Adenoviruses with E1 A or E113-55 kDa Deletions in Malignant Gliomas
by: Hong Jiang, et al.
Published: (2005-01-01) -
2-aminopurine enhances the oncolytic activity of an E1b-deleted adenovirus in hepatocellular carcinoma cells.
by: David Sharon, et al.
Published: (2013-01-01) -
Cancer imaging and therapy utilizing a novel NIS-expressing adenovirus: The role of adenovirus death protein deletion
by: Matthew Glen Robertson, et al.
Published: (2021-03-01)